![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Zydus Cadila Says its COVID-19 Vaccine Was Found Safe in Phase 1 Trial
Zydus Cadila Says its COVID-19 Vaccine Was Found Safe in Phase 1 Trial
Indian drugmaker Zydus Cadila said its COVID-19 vaccine candidate ZyCoV-D was found to be safe and well tolerated in a phase 1 clinical trial.
The company is now launching a phase 2 study to assess the vaccine’s safety and immunogenicity in more than 1,000 healthy volunteers.
In animal studies, ZyCoV-D generated high levels of neutralizing antibodies against the SARS-CoV-2 coronavirus that causes COVID-19.
Upcoming Events
-
21Oct